Stay updated on Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added 'B-cell chronic lymphocytic leukemia' as a disease keyword on the Study Details page.
    Difference
    0.1%
    Check dated 2026-04-02T15:37:29.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing the previous v3.4.3. No visible changes to study details or page layout.
    Difference
    0.1%
    Check dated 2026-03-19T06:00:37.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:37:40.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - No visible content changes between the two screenshots. The page content and structure appear identical.
    Difference
    0.1%
    Check dated 2026-02-25T21:51:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was implemented and the government operating-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:56.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Administrative updates were added: a government funding notice about NIH status and a new Revision: v3.4.1 replacing v3.4.0; these updates do not affect study details or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:25:51.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.